Mitochondrial Function in Transthyretin Amyloidosis (MIT-Amylose)
Mitochondrial Function in Transthyretin Amyloidosis : the MIT-AMYLOSE Study.
Sponsor: University Hospital Center of Martinique
Terminated
Mitochondrial respiration measurement technique faulty
Other terminated trials from University Hospital Center of Martinique
- Cancer · Sep 2023
- SARS-CoV 2 · Apr 2023
- Breast Cancer · Phase NA · Feb 2022
- HIV Infections · Phase NA · Mar 2020
- Alzheimer Disease · Phase NA · Jul 2019
See all terminations from University Hospital Center of Martinique
Other Cardiac Amyloidosis trials with similar outcome
This observational or N/A phase trial investigates Cardiac Amyloidosis and is currently terminated or withdrawn. University Hospital Center of Martinique leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Sep 2023 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Aug 2023 — Sep 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Sep 2021 — Aug 2023 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital Center of Martinique
For direct contact, visit the study record on ClinicalTrials.gov .